Braslyn Ltd., 10% Owner at Mirati Therapeutics, Inc. (MRTX), sold 24,351 shares at $197.81 ($4.8M) on 2021-03-09, disclosed to the SEC on 2021-03-10.
Open-market sale of $4.8M MRTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $191.00 | 1 | $191 | 0.0% |
| 2 | $195.82 | 1,107 | $217K | 4.5% |
| 3 | $195.82 | 1,107 | $217K | 4.5% |
| 4 | $197.30 | 4,633 | $914K | 19.0% |
| 5 | $197.30 | 4,633 | $914K | 19.0% |
| 6 | $197.81 | 3,993 |
| $790K |
| 16.4% |
| 7 | $197.81 | 3,993 | $790K | 16.4% |
| 8 | $199.08 | 2,237 | $445K | 9.3% |
| 9 | $199.08 | 2,237 | $445K | 9.3% |
| 10 | $195.52 | 189 | $37K | 0.8% |
| 11 | $195.90 | 1 | $196 | 0.0% |
| 12 | $196.12 | 20 | $4K | 0.1% |
| 13 | $198.00 | 200 | $40K | 0.8% |
| Total | $197.65 avg | 24,351 | $4.8M | 100% |
| Filing → |
| MRTX | SELL | 2019-03-05 | $19.0M | — | Filing → |
| MRTX | BUY | 2017-11-20 | $5.2M | — | Filing → |
| MRTX | BUY | 2017-01-30 | $525K | — | Filing → |